The Australia Antacids Market is witnessing consistent growth, driven by the rising prevalence of gastroesophageal reflux disease (GERD), increasing consumer awareness about digestive health, and easy accessibility of over-the-counter (OTC) medications. According to Renub Research, the Australia Antacids Market is projected to grow from US$ 134.42 million in 2024 to US$ 180.51 million by 2033, […]